Last reviewed · How we verify
Prednisone Pill
At a glance
| Generic name | Prednisone Pill |
|---|---|
| Also known as | Deltasone |
| Sponsor | University of Virginia |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Fatigue
- Back pain
- Nausea
- Hot flush
- Constipation
- Decreased appetite
- Diarrhoea
- Arthralgia
- Headache
- Hypertension
- Oedema peripheral
- Fall
Key clinical trials
- Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC (PHASE2)
- A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi (PHASE4)
- Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion) (PHASE3)
- Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose. (PHASE1)
- Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers (PHASE2)
- Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma (PHASE2)
- Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis (PHASE2)
- Gulf War Illness Inflammation Reduction Trial (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Prednisone Pill CI brief — competitive landscape report
- Prednisone Pill updates RSS · CI watch RSS
- University of Virginia portfolio CI